Inferring sources of substandard and falsified products in pharmaceutical supply chains
Authors:
- 3 March 2023
- journal article
- research article
- Published by Taylor & Francis in IISE Transactions
- Vol. 56 (3) , 241-256
Abstract
Substandard and falsified pharmaceuticals, prevalent in low- and middle-income countries, substantially increase levels of morbidity, mortality and drug resistance. Regulatory agencies combat this problem using post-market surveillance by collecting and testing samples where consumers purchase products. Existing analysis tools for post-market surveillance data focus attention on the locations of positive samples. This paper looks to expand such analysis through underutilized supply-chain information to provide inference on sources of substandard and falsified products. We first establish the presence of unidentifiability issues when integrating this supply-chain information with surveillance data. We then develop a Bayesian methodology for evaluating substandard and falsified sources that extracts utility from supply-chain information and mitigates unidentifiability while accounting for multiple sources of uncertainty. Using de-identified surveillance data, we show the proposed methodology to be effective in providing valuable inference.Keywords
All Related Versions
Funding Information
- National Science Foundation
This publication has 24 references indexed in Scilit:
- Technologies for Detecting Falsified and Substandard Drugs in Low and Middle-Income CountriesPLOS ONE, 2014
- Poor quality vital anti-malarials in Africa - an urgent neglected public health priorityMalaria Journal, 2011
- Guidelines for Field Surveys of the Quality of Medicines: A ProposalPLOS Medicine, 2009
- Using social network analysis to target criminal networksTrends in Organized Crime, 2008
- Locating Key Actors in Social Networks Using Bayes’ Posterior Probability FrameworkLecture Notes in Computer Science, 2008
- Modeling Movie Life Cycles and Market ShareMarketing Science, 2005
- The Global Threat of Counterfeit Drugs: Why Industry and Governments Must Communicate the DangersPLOS Medicine, 2005
- Network Tomography: Recent DevelopmentsStatistical Science, 2004
- Time-Varying Network Tomography: Router Link DataJournal of the American Statistical Association, 2000
- Bayesian Inference on Network Traffic Using Link Count DataJournal of the American Statistical Association, 1998